A Renewed Focus on the Association Between Thyroid Hormones and Lipid Metabolism

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2018 Sep 21

PMID 30233497

Citations 66

Authors

Leonidas H Duntas

Gabriela Brenta

Affiliations

Soon will be listed here.

Abstract

Thyroid dysfunction, manifesting as either overt or subclinical hypothyroidism, negatively affects lipid metabolism: this leads to hypercholesterolemia which progressively increases the risk for cardiovascular disease and, potentially, mortality. Hypercholesterolemia in hypothyroidism is mainly due to a reduction in low-density lipoprotein (LDL) receptor activity, this accompanied by concomitant diminishing control by triiodothyronine (T3) of sterol regulatory element-binding protein 2 (SREBP-2), which modulates cholesterol biosynthesis by regulating rate-limit degrading enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA) activity. Recently, 3,5-diiodothyronine (T2), a natural thyroid hormone derivative, was found to repress the transcription factor carbohydrate-response element-binding protein (ChREBP) and also to be involved in lipid catabolism and lipogenesis, though via a different pathway than that of T3. While thyroid hormone could therapeutically reverse the dyslipidemic profile commonly occurring in hypothyroidism, it should be borne in mind that the potency of the effects may be age-and sex-dependent. Thyroid hormone administration possibly also sustains and enhances the efficacy of hypolipidemic drugs, such as statins, ezetimibe and proprotein convertase subtilisin/kexin type 9 (PCSK9), in patients with dyslipidemia and hypothyroidism.

Citing Articles

Hypothyroidism/subclinical hypothyroidism and metabolic dysfunction-associated steatotic liver disease: advances in mechanism and treatment.

Pu S, Zhao B, Jiang Y, Cui X Lipids Health Dis. 2025; 24(1):75.

PMID: 40016726 PMC: 11866868. DOI: 10.1186/s12944-025-02474-0.

Exploring the Muscle-to-Fat Ratio of Pediatric Patients with Thyroid Disorders and Its Interaction with Thyroid Function and Metabolic Syndrome Components.

Brener A, Stark Y, Friedman Miron G, Averbuch S, Elkon-Tamir E, Borger O J Clin Med. 2025; 14(4).

PMID: 40004786 PMC: 11856726. DOI: 10.3390/jcm14041255.

Central Hypothyroidism with Low TSH Compared to Normal TSH Is Associated with More Advanced Pituitary Disease and Less Favorable Metabolic Profile.

Matusiak A, Stepniak J, Lewandowski K, Lewinski A, Karbownik-Lewinska M Metabolites. 2025; 15(2).

PMID: 39997750 PMC: 11857551. DOI: 10.3390/metabo15020125.

Hypothyroidism impairs the circadian rhythmicity of clock genes and proteins involved in gut nutrient absorption in female mice.

Secio-Silva A, Evangelista-Silva P, Emrich F, Selvatici-Tolentino L, Ferreira M, Silva A Front Physiol. 2025; 16:1515437.

PMID: 39958687 PMC: 11825765. DOI: 10.3389/fphys.2025.1515437.

Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and serum thyroid function measures: Recent Findings from NHANES 2007-2012 and Mendelian randomization.

Tan M, Zhang P, Wu S, Zhu S, Gao M Front Endocrinol (Lausanne). 2025; 16:1467254.

PMID: 39926348 PMC: 11802436. DOI: 10.3389/fendo.2025.1467254.

References

Davis Jr H, Basso F, Hoos L, Tetzloff G, Lally S, Altmann S . Cholesterol homeostasis by the intestine: lessons from Niemann-Pick C1 Like 1 [NPC1L1). Atheroscler Suppl. 2008; 9(2):77-81. DOI: 10.1016/j.atherosclerosissup.2008.05.008. View

Razvi S, Ingoe L, Keeka G, Oates C, McMillan C, Weaver J . The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. J Clin Endocrinol Metab. 2007; 92(5):1715-23. DOI: 10.1210/jc.2006-1869. View

Waring A, Rodondi N, Harrison S, Kanaya A, Simonsick E, Miljkovic I . Thyroid function and prevalent and incident metabolic syndrome in older adults: the Health, Ageing and Body Composition Study. Clin Endocrinol (Oxf). 2011; 76(6):911-8. PMC: 3334430. DOI: 10.1111/j.1365-2265.2011.04328.x. View

Li X, Wang Y, Guan Q, Zhao J, Gao L . The lipid-lowering effect of levothyroxine in patients with subclinical hypothyroidism: A systematic review and meta-analysis of randomized controlled trials. Clin Endocrinol (Oxf). 2017; 87(1):1-9. DOI: 10.1111/cen.13338. View

Damiano F, Rochira A, Gnoni A, Siculella L . Action of Thyroid Hormones, T3 and T2, on Hepatic Fatty Acids: Differences in Metabolic Effects and Molecular Mechanisms. Int J Mol Sci. 2017; 18(4). PMC: 5412329. DOI: 10.3390/ijms18040744. View

Zhao M, Tang X, Yang T, Zhang B, Guan Q, Shao S . Lipotoxicity, a potential risk factor for the increasing prevalence of subclinical hypothyroidism?. J Clin Endocrinol Metab. 2015; 100(5):1887-94. DOI: 10.1210/jc.2014-3987. View

Lin F, Tseng W, Yin W, Yeh H, Chen J, Wu C . Residual Risk Factors to Predict Major Adverse Cardiovascular Events in Atherosclerotic Cardiovascular Disease Patients with and without Diabetes Mellitus. Sci Rep. 2017; 7(1):9179. PMC: 5569020. DOI: 10.1038/s41598-017-08741-0. View

Ito M, Arishima T, Kudo T, Nishihara E, Ohye H, Kubota S . Effect of levo-thyroxine replacement on non-high-density lipoprotein cholesterol in hypothyroid patients. J Clin Endocrinol Metab. 2006; 92(2):608-11. DOI: 10.1210/jc.2006-1605. View

Kanaya A, Harris F, Volpato S, Perez-Stable E, Harris T, Bauer D . Association between thyroid dysfunction and total cholesterol level in an older biracial population: the health, aging and body composition study. Arch Intern Med. 2002; 162(7):773-9. DOI: 10.1001/archinte.162.7.773. View

10.

Obregon M . Adipose tissues and thyroid hormones. Front Physiol. 2015; 5:479. PMC: 4263094. DOI: 10.3389/fphys.2014.00479. View

11.

Brenta G, Berg G, Miksztowicz V, Lopez G, Lucero D, Faingold C . Atherogenic Lipoproteins in Subclinical Hypothyroidism and Their Relationship with Hepatic Lipase Activity: Response to Replacement Treatment with Levothyroxine. Thyroid. 2016; 26(3):365-72. DOI: 10.1089/thy.2015.0140. View

12.

Surks M, Hollowell J . Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab. 2007; 92(12):4575-82. DOI: 10.1210/jc.2007-1499. View

13.

Duntas L, Wartofsky L . Cardiovascular risk and subclinical hypothyroidism: focus on lipids and new emerging risk factors. What is the evidence?. Thyroid. 2007; 17(11):1075-84. DOI: 10.1089/thy.2007.0116. View

14.

Tagami T, Kimura H, Ohtani S, Tanaka T, Tanaka T, Hata S . Multi-center study on the prevalence of hypothyroidism in patients with hypercholesterolemia. Endocr J. 2011; 58(6):449-57. DOI: 10.1507/endocrj.k11e-012. View

15.

Hamilton-Craig I, Colquhoun D, Kostner K, Woodhouse S, dEmden M . Lipid-modifying therapy in the elderly. Vasc Health Risk Manag. 2015; 11:251-63. PMC: 4437602. DOI: 10.2147/VHRM.S40474. View

16.

Geng H, Zhang X, Wang C, Zhao M, Yu C, Zhang B . Even mildly elevated TSH is associated with an atherogenic lipid profile in postmenopausal women with subclinical hypothyroidism. Endocr Res. 2014; 40(1):1-7. DOI: 10.3109/07435800.2013.879166. View

17.

Yamashita S, Sakai N, Hirano K, Ishigami M, Maruyama T, Nakajima N . Roles of plasma lipid transfer proteins in reverse cholesterol transport. Front Biosci. 2001; 6:D366-87. DOI: 10.2741/yamashita. View

18.

Piepoli M, Hoes A, Agewall S, Albus C, Brotons C, Catapano A . 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by.... Eur Heart J. 2016; 37(29):2315-2381. PMC: 4986030. DOI: 10.1093/eurheartj/ehw106. View

19.

Heima N, Eekhoff E, Oosterwerff M, Lips P, van Schoor N, Simsek S . Thyroid function and the metabolic syndrome in older persons: a population-based study. Eur J Endocrinol. 2012; 168(1):59-65. DOI: 10.1530/EJE-12-0375. View

20.

Brenta G, Berg G, Arias P, Zago V, Schnitman M, Muzzio M . Lipoprotein alterations, hepatic lipase activity, and insulin sensitivity in subclinical hypothyroidism: response to L-T(4) treatment. Thyroid. 2007; 17(5):453-60. DOI: 10.1089/thy.2006.0302. View